Literature DB >> 19027281

Relation of sputum colour to bacterial load in acute exacerbations of COPD.

M G J Brusse-Keizer1, A J Grotenhuis, H A M Kerstjens, M C Telgen, J van der Palen, M G R Hendrix, P D L P M van der Valk.   

Abstract

BACKGROUND: When COPD patients present with an exacerbation, one cannot verify a bacterial cause of an exacerbation without time-consuming laboratory analyses. This makes it difficult to decide up front if antibiotic treatment is needed. Therefore, in clinical practice sputum colour and purulence are often used.
OBJECTIVE: To determine whether sputum colour and purulence, assessed by the Stockley colour chart, correlated with overall bacterial load in COPD patients admitted for an exacerbation. To check the robustness of the colour and purulence assessment, we correlated the changes in these parameters and the corresponding change in bacterial load in sputum over the first seven days of hospitalisation.
METHODS: Twenty-two COPD patients admitted to the hospital for an exacerbation were included. During the first seven days daily sputum samples were collected.
RESULTS: A very weak association between bacterial load and sputum colour was found. There was no difference in bacterial load between patients with purulent sputum or not. Also, no consistent relationship between change in sputum colour and change in bacterial load during admission was found.
CONCLUSIONS: The very weak association between bacterial load and sputum colour confirms concerns over the usefulness of the colour chart. The distinction between purulent and mucoid sputum at exacerbation is insufficient for distinction between patients who are likely to benefit from antibiotic therapy and those who are not. Complementary studies are needed to determine which other, easily measurable factors can be used as predictors for an indication for use of antibiotics; sputum colour is not the one.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027281     DOI: 10.1016/j.rmed.2008.10.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  14 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Diagnostic Stewardship of Endotracheal Aspirate Cultures in a PICU.

Authors:  Anna C Sick-Samuels; Matthew Linz; Jules Bergmann; James C Fackler; Sean M Berenholtz; Shawn L Ralston; Katherine Hoops; Joe Dwyer; Elizabeth Colantuoni; Aaron M Milstone
Journal:  Pediatrics       Date:  2021-04-07       Impact factor: 7.124

3.  Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.

Authors:  Robert Wilson; Antonio Anzueto; Marc Miravitlles; Pierre Arvis; Jeff Alder; Daniel Haverstock; Mila Trajanovic; Sanjay Sethi
Journal:  Eur Respir J       Date:  2011-12-01       Impact factor: 16.671

Review 4.  When should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelines.

Authors:  Johanna Laue; Eirik Reierth; Hasse Melbye
Journal:  NPJ Prim Care Respir Med       Date:  2015-02-19       Impact factor: 2.871

5.  Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study.

Authors:  Emanuel Citgez; Job van der Palen; Kirsten Koehorst-Ter Huurne; Kris Movig; Paul van der Valk; Marjolein Brusse-Keizer
Journal:  BMJ Open Respir Res       Date:  2016-06-17

6.  Patterns and characterization of COPD exacerbations using real-time data collection.

Authors:  Stanley I Ejiofor; Jan Stolk; Pablo Fernandez; Robert A Stockley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-25

Review 7.  Lung microbiology and exacerbations in COPD.

Authors:  Victoria Beasley; Priya V Joshi; Aran Singanayagam; Philip L Molyneaux; Sebastian L Johnston; Patrick Mallia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-08-31

Review 8.  Pulmonary biomarkers in COPD exacerbations: a systematic review.

Authors:  Angela Koutsokera; Konstantinos Kostikas; Laurent P Nicod; Jean-William Fitting
Journal:  Respir Res       Date:  2013-10-21

Review 9.  Action plans for COPD: strategies to manage exacerbations and improve outcomes.

Authors:  Leena Jalota; Vipul V Jain
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-02

10.  Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.

Authors:  Eylem Acartürk Tunçay; Zuhal Karakurt; Emine Aksoy; Cuneyt Saltürk; Sinem Gungor; Nezihe Ciftaslan; İlim Irmak; Dilek Yavuz; Birsen Ocakli; Nalan Adıgüzel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.